Assessing the Effectiveness of Treatment for Congenital Hydronephrosis in Children

Authors

  • O. K. Sapayev Urgench State Medical Institute Urgench, Uzbekistan
  • I. B. Ruzmatov Urgench State Medical Institute Urgench, Uzbekistan
  • Q. O. Sapayev Urgench State Medical Institute Urgench, Uzbekistan

Keywords:

High-grade dilatation, hydronephrosis, progressive dilatation

Abstract

Congenital hydronephrosis is one of the most frequently detected urinary tract abnormalities during the antenatal period. Its clinical significance ranges from mild, transient pyelectasis to obstructive uropathies that may lead to progressive deterioration of renal function. The widespread implementation of antenatal ultrasonography has substantially increased the detection of fetal urinary tract dilatation. Studies conducted in European countries have reported a prevalence of congenital hydronephrosis of 11.5 cases per 10,000 births; in 86% of affected children, the renal anomaly was isolated. Not all cases of antenatally detected hydronephrosis are associated with pathological obstruction. The literature indicates that approximately one-third of antenatal urinary tract dilatations may regress before birth, while another proportion may resolve spontaneously during the first years of life. However, persistent or high-grade dilatation may be associated with ureteropelvic junction obstruction, vesicoureteral reflux, and other congenital anomalies of the kidneys and urinary tract. Therefore, the key clinical issue is not merely early detection of hydronephrosis, but also accurate assessment of its clinical significance and timely identification of children at risk of renal functional impairment.

References

[1] European Association of Urology, “EAU Guidelines on Paediatric Urology: Dilatation of the Upper Urinary Tract (PUJ Obstruction),” 2026. [Online]. Available: https://uroweb.org/guidelines/paediatric-urology/chapter/dilatation-of-the-upper-urinary-tract-puj-obstruction

[2] J. Wong, M. Rickard, J. Dos Santos, and A. J. Lorenzo, “Antenatal hydronephrosis: An updated review on postnatal care and management,” Current Opinion in Pediatrics, vol. 37, no. 5, pp. 473–481, 2025, doi: 10.1097/MOP.0000000000001485.

[3] E. Garne et al., “Congenital hydronephrosis: Prenatal diagnosis and epidemiology in Europe,” Journal of Pediatric Urology, vol. 5, no. 1, pp. 47–52, 2009, doi: 10.1016/j.jpurol.2008.08.010.

[4] H. T. Nguyen et al., “The Society for Fetal Urology consensus statement on the evaluation and management of antenatal hydronephrosis,” Journal of Pediatric Urology, vol. 6, no. 3, pp. 212–231, 2010, doi: 10.1016/j.jpurol.2010.02.205.

[5] A. Sinha, A. Bagga, A. Krishna, et al., “Revised guidelines on management of antenatal hydronephrosis,” Indian Journal of Nephrology, vol. 23, no. 2, pp. 83–97, 2013, doi: 10.4103/0971-4065.109403.

[6] H. T. Nguyen et al., “Multidisciplinary consensus on the classification of prenatal and postnatal urinary tract dilation (UTD classification system),” Journal of Pediatric Urology, vol. 10, no. 6, pp. 982–998, 2014.

[7] J. P. Capolicchio, L. H. Braga, and K. M. Szymanski, “Canadian Urological Association/Pediatric Urologists of Canada guideline on the investigation and management of antenatally detected hydronephrosis,” Canadian Urological Association Journal, vol. 12, no. 4, pp. 85–92, 2018, doi: 10.5489/cuaj.5094.

[8] M. Rickard, J. Dos Santos, J. Keunen, and A. J. Lorenzo, “Prenatal hydronephrosis: Bridging pre- and postnatal management,” Prenatal Diagnosis, vol. 42, no. 9, pp. 1081–1093, 2022, doi: 10.1002/pd.6114.

[9] M. Rickard et al., “Evolving trends in peri-operative management of pediatric ureteropelvic junction obstruction: Working towards quicker recovery and day surgery pyeloplasty,” World Journal of Urology, vol. 39, no. 9, pp. 3677–3684, 2021, doi: 10.1007/s00345-021-03621-9.

[10] R. B. I. Christanto et al., “Long-term renal function post-pyeloplasty: A systematic review,” International Urology and Nephrology, vol. 57, no. 10, pp. 3107–3115, 2025, doi: 10.1007/s11255-025-04495-1.

[11] E. J. Wehbi et al., “The conundrum of high-grade hydronephrosis with non-obstructive drainage on diuretic renography,” Journal of Pediatric Urology, vol. 20, suppl. 1, pp. S11–S17, 2024, doi: 10.1016/j.jpurol.2024.05.017.

[12] D. Dindo, N. Demartines, and P.-A. Clavien, “Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey,” Annals of Surgery, vol. 240, no. 2, pp. 205–213, 2004, doi: 10.1097/01.sla.0000133083.54934.ae.

[13] A. Onen, “Grading of hydronephrosis: An ongoing challenge,” Frontiers in Pediatrics, vol. 8, art. no. 458, 2020, doi: 10.3389/fped.2020.00458.

[14] C. D. A. Herndon et al., “Perinatal urinary tract dilation: Recommendations on pre-/postnatal imaging, prophylactic antibiotics, and follow-up: Clinical report,” Pediatrics, vol. 156, no. 1, art. no. e2025071814, 2025, doi: 10.1542/peds.2025-071814.

[15] J. C. Anderson and W. Hynes, “Plastic operation for hydronephrosis,” Proceedings of the Royal Society of Medicine, vol. 44, no. 1, pp. 4–5, 1951, doi: 10.1177/003591575104400102.

Downloads

Published

2026-11-13

How to Cite

O. K. Sapayev, I. B. Ruzmatov, & Q. O. Sapayev. (2026). Assessing the Effectiveness of Treatment for Congenital Hydronephrosis in Children. International Journal of Pediatrics and Genetics , 4(11), 8–11. Retrieved from https://medicaljournals.eu/index.php/IJPG/article/view/3043